MedTrace Logo

Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy

NCT04858594 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2022-04-11

No results posted yet for this study

Summary

This is a prospective, observational study to establish the connection between periodontitis and BSI in AML patients planning to receive intensive chemotherapy.

Conditions

Interventions

OTHER

Planned Chemotherapy

standard oncologic supportive care including antibiotic prophylaxis

Sponsors & Collaborators

  • Masonic Cancer Center, University of Minnesota

    lead OTHER

Principal Investigators

  • Armin Rashidi, MD, PhD · Masonic Cancer Center, University of Minnesota

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-04
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04858594 on ClinicalTrials.gov